D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 85 Citations 34,491 288 World Ranking 9435 National Ranking 5010

Overview

What is she best known for?

The fields of study she is best known for:

  • Cancer
  • Internal medicine
  • Gene

Her primary areas of study are Internal medicine, Breast cancer, Oncology, Cancer and Gynecology. In the field of Internal medicine, her study on Prostate cancer, Case-control study, Survival rate and Incidence overlaps with subjects such as Risk assessment. Saundra S. Buys combines subjects such as Cancer research, Genome-wide association study, Single-nucleotide polymorphism, Genetic predisposition and Family history with her study of Breast cancer.

Her work carried out in the field of Oncology brings together such families of science as Gene mutation, Ovarian cancer, Triple-negative breast cancer, Genetic testing and Risk factor. As a part of the same scientific study, Saundra S. Buys usually deals with the Cancer, concentrating on TOX3 and frequently concerns with Genetic association. Saundra S. Buys interconnects Colorectal cancer, Randomized controlled trial and Mass screening in the investigation of issues within Gynecology.

Her most cited work include:

  • Mortality Results from a Randomized Prostate-Cancer Screening Trial (2328 citations)
  • A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer (1364 citations)
  • Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial. (841 citations)

What are the main themes of her work throughout her whole career to date?

Her main research concerns Breast cancer, Internal medicine, Oncology, Cancer and Gynecology. Her Breast cancer research includes elements of Prospective cohort study, Single-nucleotide polymorphism, Family history and Cohort. Her work in the fields of Internal medicine, such as Ovarian cancer, Cancer screening, Prostate and Prostate cancer, overlaps with other areas such as Risk assessment.

Her study in Cancer screening is interdisciplinary in nature, drawing from both Randomized controlled trial and Mass screening. Her biological study deals with issues like Cancer research, which deal with fields such as Gene. Her Gynecology research is multidisciplinary, incorporating perspectives in Odds ratio, Confidence interval and Risk factor.

She most often published in these fields:

  • Breast cancer (66.89%)
  • Internal medicine (55.18%)
  • Oncology (43.81%)

What were the highlights of her more recent work (between 2018-2021)?

  • Breast cancer (66.89%)
  • Internal medicine (55.18%)
  • Oncology (43.81%)

In recent papers she was focusing on the following fields of study:

Saundra S. Buys mainly focuses on Breast cancer, Internal medicine, Oncology, Prospective cohort study and Family history. Her research on Breast cancer concerns the broader Cancer. Her research on Internal medicine focuses in particular on Odds ratio.

Her research in Oncology intersects with topics in Young adult, Mutation, Ovarian cancer, Hazard ratio and Prostate cancer. Her Prospective cohort study research incorporates themes from Retrospective cohort study, Natural menopause, Proportional hazards model and BRCA2 Mutation. Her Family history research incorporates elements of Psychological intervention, Gynecology and Epidemiology.

Between 2018 and 2021, her most popular works were:

  • Genetic/familial high-risk assessment: Breast, ovarian, and pancreatic, version 1.2020 featured updates to the NCCN guidelines (94 citations)
  • 10-year performance of four models of breast cancer risk: a validation study. (51 citations)
  • 10-year performance of four models of breast cancer risk: a validation study. (51 citations)

In her most recent research, the most cited papers focused on:

  • Cancer
  • Internal medicine
  • Gene

The scientist’s investigation covers issues in Breast cancer, Prospective cohort study, Risk assessment, Internal medicine and Cohort. The Breast cancer study combines topics in areas such as Obstetrics, Cancer research and Risk factor. Saundra S. Buys has researched Prospective cohort study in several fields, including Hazard ratio, Incidence, Cohort study and Family history.

Internal medicine is closely attributed to Oncology in her study. The various areas that Saundra S. Buys examines in her Oncology study include Ovarian cancer and Prostate cancer. In her research, Metabolic equivalent, Physical activity level and Body mass index is intimately related to BRCA mutation, which falls under the overarching field of Cohort.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Mortality Results from a Randomized Prostate-Cancer Screening Trial

Gerald L. Andriole;E. David Crawford;Robert L. Grubb;Saundra S. Buys.
The New England Journal of Medicine (2009)

3739 Citations

A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer

David J Hunter;David J Hunter;Peter Kraft;Kevin B Jacobs;David G Cox.
Nature Genetics (2007)

1739 Citations

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers

Karoline B. Kuchenbaecker;Karoline B. Kuchenbaecker;John L. Hopper;Daniel R. Barnes;Kelly-Anne Phillips.
JAMA (2017)

1731 Citations

Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial.

Saundra S. Buys;Edward Partridge;Amanda Black;Christine C. Johnson.
JAMA (2011)

1411 Citations

Prostate Cancer Screening in the Randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: Mortality Results after 13 Years of Follow-up

Gerald L. Andriole;E. David Crawford;Robert L. Grubb;Saundra S. Buys.
Journal of the National Cancer Institute (2012)

1365 Citations

The national lung screening trial: Overview and study design

Constantine A. Gatsonis;Denise R. Aberle;Christine D. Berg;William C. Black.
Radiology (2011)

1111 Citations

Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy

Robert E. Schoen;Paul F. Pinsky;Joel L. Weissfeld;Lance A. Yokochi.
The New England Journal of Medicine (2012)

1058 Citations

Design of the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial

Philip C Prorok;Gerald L Andriole;Robert S. Bresalier;Saundra S Buys.
Controlled Clinical Trials (2000)

979 Citations

Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes

Yoko S. Derose;Guoying Wang;Yi Chun Lin;Philip S. Bernard.
Nature Medicine (2011)

926 Citations

Breast-Cancer Risk in Families with Mutations in PALB2

A. C. Antoniou;S. Casadei;T. Heikkinen;D. Barrowdale.
The New England Journal of Medicine (2014)

907 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Saundra S. Buys

Graham G. Giles

Graham G. Giles

University of Melbourne

Publications: 311

Melissa C. Southey

Melissa C. Southey

Monash University

Publications: 231

Roger L. Milne

Roger L. Milne

Cancer Council Victoria

Publications: 209

John L. Hopper

John L. Hopper

University of Melbourne

Publications: 207

Douglas F. Easton

Douglas F. Easton

University of Trieste

Publications: 204

Esther M. John

Esther M. John

Stanford University

Publications: 192

Paul D.P. Pharoah

Paul D.P. Pharoah

University of Cambridge

Publications: 191

Stephen J. Chanock

Stephen J. Chanock

National Institutes of Health

Publications: 189

David J. Hunter

David J. Hunter

University of Oxford

Publications: 175

Irene L. Andrulis

Irene L. Andrulis

University of Toronto

Publications: 172

Jenny Chang-Claude

Jenny Chang-Claude

German Cancer Research Center

Publications: 170

Fergus J. Couch

Fergus J. Couch

Mayo Clinic

Publications: 163

Steven A. Narod

Steven A. Narod

University of Toronto

Publications: 159

Peter Kraft

Peter Kraft

Harvard University

Publications: 150

Georgia Chenevix-Trench

Georgia Chenevix-Trench

QIMR Berghofer Medical Research Institute

Publications: 143

Christopher A. Haiman

Christopher A. Haiman

University of Southern California

Publications: 140

Trending Scientists

John E. Laird

John E. Laird

University of Michigan–Ann Arbor

Shi-Min Hu

Shi-Min Hu

Tsinghua University

Jan Verwer

Jan Verwer

Centrum Wiskunde & Informatica

V. V. Dodonov

V. V. Dodonov

University of Brasília

Bo-Ping Zhang

Bo-Ping Zhang

University of Science and Technology Beijing

Vasily V. Bulatov

Vasily V. Bulatov

Lawrence Livermore National Laboratory

Miguel Vidal

Miguel Vidal

Spanish National Research Council

Jean-David Rochaix

Jean-David Rochaix

University of Geneva

Hamlyn G. Jones

Hamlyn G. Jones

University of Western Australia

Tania F. Gendron

Tania F. Gendron

Mayo Clinic

Jeffrey W. Smith

Jeffrey W. Smith

Sanford Burnham Prebys Medical Discovery Institute

H. Chris Dijkerman

H. Chris Dijkerman

Utrecht University

Philip J. Corr

Philip J. Corr

City, University of London

Osamu Ishikawa

Osamu Ishikawa

Gunma University

Per Björntorp

Per Björntorp

University of Gothenburg

William F. Bottke

William F. Bottke

Southwest Research Institute

Something went wrong. Please try again later.